Who We Are
Bioinformatix designed and developed a patent-pending software program, Rx&You(TM), which is a cloud-based artificial intelligence platform that remotely monitors patient medication behavior in real-time across their whole regimen, and intervenes when appropriate to help solve medication non-adherence, and pharmacovigilance, and coordinates care across many providers to solve polypharmacy. It also creates large volumes of patient-generated data about medication treatment for Big Data analytics to provide major opportunities for maximizing treatment.
In addition, the platform helps pharmaceutical companies satisfy regulations in the US, Europe, and 27 American states that now require electronic reporting of adverse events.
For patients, this means having a reminder system for their whole medication regimen that is patient-centric, (e.g., mobile call vs. email vs. SMS text vs. direct messaging). Our patient-centric reminder system also allows patients to prioritize medications differently thereby improving access to the right type of intervention when they need it most.
For providers, this means illuminating a dark void of information to improve care quality. With Rx&You, quality improves because the provider knows in advance who is not adhering to their regimens on a dose-by-dose basis for every medication, when, and why. The provider literally goes from not knowing who, what, when, or why – to knowing all these things for every patient and medication in near real-time.
Payers benefit because they inure financial savings from cost prevention and containment. By decreasing non-adherence and adverse events, and coordinating care, treatment costs can be prevented from increasing, often by thousands of dollars per patient per year.
The IdeaSeptember 2015
The 2 founders had a new idea to improve patient adherence to medications.
First DemoFebruary 2016
The first demo of the RX&You™ platform was given at Massachusetts General Hospital.
First AdvisorMarch 2016
Bioinformatix signed its first advisor from the health insurance sector.
Provisional Patent FiledApril 2016
The RX&You™ patents filed at the US Patent & Trademark Office by Fenwick & West.
Top 10 InsuranceJuly 2016
Began due diligence with first Top 10 insurance carrier.
COO namedAugust 2016
Bioinformatix appointed Jeffrey Weiss as its first Chief Operating Officer.
Additional AdvisorsAugust 2016
Bioinformatix signs two additional advisors from the pharmaceutical and intellectual property sectors.
First Pharmaceutical PilotAugust 2016
RX&You™ Platform pilot invitation from top 10 pharmaceutical company.
First Research Hospital PilotSeptember 2016
RX&You™ Platform pilot invitation from first medical research hospital.
Astellas C3Prize FinalistSeptember 2016
Bioinformatix was chosen as a top 5 finalist out of 120 entries for its RX&You™ platform.
Found by PressSeptember 2016
Eligible says RX&You™ 1 of 7 healthcare start-ups you should know.
World Tech FinalistNovember 2016
RX&You™ chosen as 1 of 6 global finalists for WTN Award in health and medicine.
Startup Boot Camp ChinaMay 2017
Bioinformatix chosen as the only U.S. digital health company for the inaugural cohort of start-ups.
First RoadshowSeptember 2017
Complete first technology road show in China presenting in 5 major cities.
International Makers FestivalSeptember 2017
Guangzhou-Foshan 2017 International Makers Festival picks Rx&You to pitch.
AI+Pharma and HealthcareOctober 2017
Rx&You™ presents at the 2017 AI+Pharma and Healthcare Innovation Summit.
City of TaizhouNovember 2017
The city of Taizhou, China selects Rx&You™ to present.
Startup Festival 2017December 2017
Bioinformatix presents on AI in Healthcare at Startup Festival 2017 in Seoul, South Korea.